Larson Financial Group’s Fulgent Genetics FLGT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
– Sell
-1,000
Closed -$15.9K – 3832
2026
Q1
$15.9K Buy
1,000
+973
+3,604% +$21.1K ﹤0.01% 1973
2025
Q4
$709 Hold
27
– – ﹤0.01% 3038
2025
Q3
$610 Sell
27
-100
-79% -$2.06K ﹤0.01% 3059
2025
Q2
$2.52K Hold
127
– – ﹤0.01% 2334
2025
Q1
$2.15K Buy
+127
New +$2.16K ﹤0.01% 2150
2024
Q4
– Sell
-47
Closed -$1.02K – 2819
2024
Q3
$1.02K Hold
47
– – ﹤0.01% 1985
2024
Q2
$922 Sell
47
-100
-68% -$2.09K ﹤0.01% 1726
2024
Q1
$3.19K Buy
147
+100
+213% +$2.48K ﹤0.01% 1280
2023
Q4
$1.36K Hold
47
– – ﹤0.01% 1417
2023
Q3
$1.26K Hold
47
– – ﹤0.01% 1452
2023
Q2
$1.74K Hold
47
– – ﹤0.01% 1287
2023
Q1
$1.47K Hold
47
– – ﹤0.01% 1292
2022
Q4
$1.4K Hold
47
– – ﹤0.01% 1245
2022
Q3
$2K Hold
47
– – ﹤0.01% 1112
2022
Q2
$3K Hold
47
– – ﹤0.01% 955
2022
Q1
$3K Hold
47
– – ﹤0.01% 858
2021
Q4
$5K Buy
+47
New +$4.13K ﹤0.01% 807

Other funds holding FLGT

Larson Financial Group's FLGT Position: Q2 2026 in Review

Larson Financial Group sold out of Fulgent Genetics (FLGT) in Q2 2026, closing a stake of 1,000 shares — an estimated $15.9K sold.

Larson Financial Group first reported a position in FLGT in Q4 2021 and held it in 17 quarters. The position peaked at $15.9K in Q1 2026. 141 funds tracked by Wall St. Rank hold FLGT as of Q2 2026.

  • Larson Financial Group reported no remaining Fulgent Genetics position as of Q2 2026 after selling out during the quarter.
  • Larson Financial Group sold 1,000 Fulgent Genetics shares in Q2 2026, an estimated $15.9K.
  • Larson Financial Group first reported a position in Fulgent Genetics in Q4 2021 and held it in 17 quarters.
  • Larson Financial Group's Fulgent Genetics position peaked at $15.9K in Q1 2026.
  • 141 funds tracked by Wall St. Rank held Fulgent Genetics as of Q2 2026.

Based on Larson Financial Group's 13F filing for Q2 2026, filed 14 Aug 2026.